foxo4-dri senolytic 2023 2024 study

foxo4-dri senolytic 2023 2024 study peptide mouse Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI Peptide inhibitors targeting FOXO4-p53 interactions

Name: foxo4-dri senolytic 2023 2024 study peptide mouse Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI Peptide inhibitors targeting FOXO4-p53 interactions
Brand: lagence-mr.com
SKU: 35099004631
Price: 25.26 USD
Availability: InStock
Rating: 4.5598 (19 reviews)

Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv foxo4 dri senolytic peptide human trial 2024 FOXO4 DRI UK Senolytic Peptide Research The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging

SKU: 35099004631 · From lagence-mr.com

4.6

USD25.26 USD62.26

Pay in 4 interest-free payments of $6.32 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 23 - Sep 28

Description

they are the foundation of reproducible, publication-ready data

Lamination-based organoid spatially resolved transcriptomics technique for primary lung and liver organoid characterization

B., Oreskovic, I., Ziger, T., Novinscak, T., Krezic, I., Strbe, S., Drinkovic, M., Brkic, F., Popic, J., Skrtic, A., Seiwerth, S., Staresinic, M., Sikiric, P.,